lobbying_activities: 1991496

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1991496	9c863313-bc09-450c-a38a-e682718e5be4	Q2	CAPITOL HILL STRATEGIES, LLC	91774	BIOGEN INC	2017	second_quarter	MED	Issues dealing with newborn screening. H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, legislation to reauthorize the Prescription Drug User Fee Act (PDUFA), as reauthorized by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA). Issues dealing with Alzheimer's treatments	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2017-07-18T12:47:58.803000-04:00